Cargando...

Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines

Triple-negative breast cancer (TNBC) is the most challenging subtype to treat due to the lack of estrogen receptor, progesterone receptor, and HER2 expression, which excludes the usage of directed targeted therapy against them. Promising therapeutic targets are the hepatocyte growth factor receptor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Autores principales: Simiczyjew, Aleksandra, Dratkiewicz, Ewelina, Van Troys, Marleen, Ampe, Christophe, Styczeń, Ilona, Nowak, Dorota
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2018
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6162814/
https://ncbi.nlm.nih.gov/pubmed/30227653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10090335
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!